Cytosorbents Corporation
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-6.7M | $-6.9M | $140.7K | $2.8M |
| FY2017 | $-6.5M | $-7.5M | $990.7K | $3.3M |
| FY2018 | $-10.8M | $-11.5M | $672.0K | $4.4M |
| FY2019 | $-16.8M | $-17.5M | $698.2K | $1.7M |
| FY2020 | $-5.6M | $-6.3M | $708.4K | $3.5M |
| FY2021 | $-14.0M | $-17.6M | $3.6M | $4.0M |
| FY2022 | $-28.2M | $-34.3M | $6.1M | $3.4M |
| FY2023 | $-21.7M | $-22.2M | $538.1K | $4.2M |
| FY2024 | $-14.4M | $-14.7M | $284.0K | $3.8M |
| FY2025 | $-12.4M | $-12.5M | $164.0K | $2.8M |